Employers can advance innovative cancer care by tailoring benefits and support to their workforce's needs, according to Rosa Novo, executive benefits director at Miami-Dade County Public Schools ...

Keith Kaye, MD, MPH, explains how shorter antibiotic courses and optimized dosing help balance treatment efficacy against C.

Experts at ERS Congress 2026 discuss why attending respiratory conferences drives learning, networking, and better patient ...

Employers can advance patient-centered oncology care through proactive benefits, quality data, navigation, and tailored ...

Swarup Kumar, MD, emphasizes that preparation is central to positive outcomes and includes patient education and early ...

Karolinska Institutet reports ROR1 inhibitor KAN571C wipes out double‑resistant MCL after ibrutinib/venetoclax, spotlighting ...

Inebilizumab's twice-yearly CD19 dosing directly targets antibody-producing cells; trial enrollment used disease activity, ...

Leveraging 1.4 million MASH records, 11.8% had documented GLP-1 RA exposure, with dulaglutide, exenatide, liraglutide, lixisenatide, or semaglutide represented. Propensity score matching balanced ...

Hepatitis A vaccine given before exposure prevented 95.8% of laboratory-confirmed infections across 14 studies. The post-exposure dose produced a nearly identical number on far weaker footing, graded ...

Strength training was not associated with an increased risk of sustained ventricular arrhythmia among people living with or at genetic risk for arrhythmogenic cardiomyopathy (ACM) ...

FDA expanded finerenone use to CKD with type 1 diabetes to reduce UACR, positioning it as the only MRA indicated across CKD associated with type 1 and type 2 diabetes. FINE-ONE (n=242) showed ...

Most people with narcolepsy and idiopathic hypersomnia (IH) stay employed, but many struggle at work and receive little workplace support, often without disclosing their condition to employers, ...